re: Ann: Avexa announces detailed ATC Phase I... "...may provide clinical benefit..."Cutting the trial so short hasn't really advanced the cause much imho.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%